GSK
Get informed when a big investor buys or sells
+ FollowJuly 28, 2026 - AI Summary
Undervalued by 88.4% based on the discounted cash flow analysis.
| Market cap | $100.62 Billion |
|---|---|
| Enterprise Value | $115.66 Billion |
| Dividend Yield | $1.82 (3.62%) |
| Earnings per Share | $2.82 |
| Beta | 0.29 |
| Outstanding Shares | 2,007,000,000 |
| P/E Ratio | 15.65 |
|---|---|
| PEG | -22.45 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 6.21 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | 6.24 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 1.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1903▲ 63.81% |
|---|---|
| Total Calls | 2,006,200▼ 38.73% |
| Total Puts | 2,387,900▲ 32.09% |
Holdings and activity of institutional investors.
| Ownership % | 17.30%▼ 1.30% |
|---|---|
| Total Invested | $18.19B▼ 11.95% |
| Investors Holding | 1,078▲ 13.00% |
No data